Fig 1.
Description of the study population.
Table 1.
Demographic data of the study subjects with and without metabolic syndrome at baseline.
Fig 2.
The optimal cut-off values of uric acid by receiver operating characteristic curves in both genders.
Fig 3.
Kaplan-Meier plots of metabolic syndrome, hypertension and type 2 diabetes the uric acid level in both genders.
Table 2.
Univariate hazard ratios of future metabolic syndrome, hypertension and type 2 diabetes by uric acid level and metabolic syndrome components.
Table 3.
Multivariate hazard ratios of future metabolic syndrome and hypertension by uric acid level and metabolic syndrome components.